stockportfolio.pro
Stocks / DOX vs NOVT
DOX vs NOVT
Amdocs Limited and Novanta Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Technology.
| Amdocs Limited (DOX) | Novanta Inc. (NOVT) | |
|---|---|---|
| Market cap | $5.9B | $5.5B |
| Revenue (latest FY) | $4.53B | $980.60M |
| Net income (latest FY) | $564.70M | $53.83M |
| Revenue growth (5y CAGR) | -0.3% | 10.7% |
| Net margin | 12.5% | 5.5% |
| Return on equity | 16.5% | 4.1% |
| P/E ratio | 11.1 | 110.8 |
| Dividend yield | 4.0% | — |
| Profitable years (of last 10) | 4 | 10 |
| Positive free cash flow | Yes | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open DOX — free Open NOVT — freeFrequently asked questions
Which is bigger, DOX or NOVT?
Amdocs Limited is larger by market capitalization — $5.9B versus $5.5B.
Which grows faster, DOX or NOVT?
Over the last five fiscal years, Novanta Inc. grew revenue faster — 10.7%/yr versus -0.3%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.